Stem cell mobilization therapy safe for bone marrow donors, study suggests

Researchers have reported that administration of granulocyte colony-stimulating factor, a drug that releases stem cells from the bone marrow into the blood, is unlikely to put healthy stem cell donors at risk for later development of abnormalities involving loss or gains of chromosomes that have been linked to hematologic disorders such as myelodysplastic syndromes and acute myeloid leukemia.

Read the whole article on Science Daily

More from Science Daily